The forecasted share of German biotechnological publications among the world's 10% top-cited is set to decrease from 7.92% in 2024 to 6.91% by 2028. This indicates a steady decline over the five-year forecast period. Assuming 8.15% for 2023 (based on usual market assessments), we've seen a downward year-on-year trend starting this period. The average compound annual growth rate (CAGR) over these years is negative, signaling reduced competitive standing globally in high-impact biotechnology research.
Future trends to watch include potential impacts from increased investment in research and development, strategic collaborations with international institutions, and emerging biotechnology sectors like synthetic biology and personalized medicine. These could alter the downward trajectory if effectively leveraged.
